IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
1.740
+0.050 (2.96%)
Feb 11, 2026, 3:25 PM CET
Revenue by Product
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.